Refractory Peripheral T-Cell Lymphoma

Explore clinical trials studying Refractory Peripheral T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

6 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Refractory Peripheral T-Cell Lymphoma trial results

Recruiting

NCT06160843

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: National Cancer Centre, Singapore Singapore

Not Yet Recruiting

NCT06671717

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Peking University, Institute of Hematolgoy, Beijing, Beijing, China

Completed

NCT03496779

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: ZNA Stuivenberg Antwerp, Belgium

A. Z. Sint-Jan Bruges, Belgium

Clinique Universitaire Saint LUC Brussels, Belgium

Institut Jules Bordet Brussels, Belgium

View all 39 locations

Completed

NCT02106650

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: City of Hope Duarte, California, United States

Cancer Center of Kansas Wichita, Kansas, United States

Seattle Cancer Care Alliance Seattle, Washington, United States

Completed

NCT03349333

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Beijing Cancer Hospital Beijing, China

Completed

NCT01482962

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Birmingham, Alabama, United States

La Jolla, California, United States

Orlando, Florida, United States

Tampa, Florida, United States

View all 151 locations